Business Wire

SAPHETOR-SA

Share
Saphetor SA receives IVDR Certification for clinical diagnosis support NGS data analysis platform, VarSome Clinical, ensuring enhanced safety and performance standards

Saphetor SA, the creators of the global human genetics community VarSome, today announced European CE mark approval of the VarSome Clinical platform for the automated variant discovery, annotation, and interpretation of Next Generation Sequencing (NGS) data in compliance with the European Union’s In-Vitro Diagnostic Medical Devices Regulation (IVDR) (EU Regulation 2017/746 on IVD medical devices) by the notified body TÜV SÜD.

This represents a major milestone in clinical genomics, as robust standards and regulations are introduced to ensure the safety and effectiveness of medical devices. Inclusion of NGS analysis software under IVDR, is a reflection of the maturity of the technology and its importance in clinical practice. With this shift towards routine care, comes the need for transparency and reproducibly reliable performance.

IVDR, which came into full effect on 26 of May 2022, replaces the previous In-Vitro Diagnostic Medical Devices Directive (IVDD) and introduces more stringent requirements for the classification, performance evaluation, and post-market surveillance of in-vitro diagnostic devices. VarSome Clinical’s IVDR certification ensures that it meets the highest standards of safety, performance, and reliability.

As a result of IVDR coming into full effect, in-house tests (also known as Laboratory Developed Tests (LDTs)) or Research Use Only (RUO) products must comply with Article 5.5 of IVDR. This includes in particular the need to implement appropriate quality management systems, comply with the GSPR (General Safety & Performance Requirements) and set up a review process to take necessary corrective actions based on experience gained from the clinical use of the RUO product. At the end of the IVDR transition period, laboratories will no longer be allowed to use a RUO bioinformatics solution if an equivalent IVDR-certified product, such as VarSome Clinical, is commercially available.

Key benefits of VarSome Clinical’s IVDR certification:

  1. Enhanced safety and performance: VarSome Clinical has undergone rigorous performance evaluations, including scientific validity, analytical performance, and clinical performance, ensuring they meet the stringent requirements set forth by the IVDR.
  2. Improved risk management: The new risk-based system and comprehensive technical documentation provide a strong framework for identifying and reducing potential risks associated with in-vitro diagnostic devices.
  3. Strengthened market surveillance: With enhanced post-market surveillance measures, including vigilance reporting and periodic safety updates, Saphetor is committed to continuously monitor the performance and safety of VarSome Clinical.
  4. Transparency and traceability: Achieving better management of safety related issues and ensuring prompt actions when necessary.
  5. Regulatory excellence: VarSome Clinical’s IVDR certification demonstrates the dedication of Saphetor for regulatory excellence, providing confidence to healthcare professionals and patients in the quality and reliability of VarSome Clinical as a clinical diagnostic support solution.

Andreas Massouras, CEO and Founder, Saphetor SA, comments:
“The journey to IVDR certification has taken us more than two years. It has taken a lot of hard work across the company, and a lot of planning to put new processes in place. This now sets the new standard that all NGS diagnostic pipelines need to adhere to. Ensuring patient safety, through transparent and robust processes is crucial at this point in time. Genomic data is already having a major impact on healthcare, and so it is now critically important that it meet the standards that the rest of established medical practices have to meet. This is an exciting time, as it shows that genomics is now moving beyond clinical research and into routine clinical care. We are exceptionally proud to be amongst the first bioinformatics platforms to be awarded a CE mark under IVDR, and we look forward to continuing to help advance human health with our VarSome Clinical partners.”

Amélie Martinez, RAQA Director, Saphetor SA, comments:
“This certification is a great achievement and rewards all our efforts in meeting the IVDR requirements, both with the medical device documentation and our Quality Management System. We are proud to be able to provide Healthcare Professionals and diagnostic labs with an IVDR-compliant device, thus reducing their workload for process validation and giving them more time to care for patients.”

About Saphetor SA
Saphetor SA, is a global precision-medicine company dedicated to large-scale identification and interpretation of human genetic variants by leveraging proprietary algorithms and expert domain knowledge.
Saphetor is the creator of VarSome, a suite of intuitive and data-driven bioinformatics solutions both for clinicians and researchers. VarSome.com professional community and search engine is freely accessible, featuring a widely-recognized community-driven knowledge base that enables flexible queries across more than 140 genetic and genomic data resources.
VarSome Premium and VarSome Clinical are professional editions of VarSome with powerful functionality and further sophisticated data-mining and analysis tools. VarSome Clinical is a IVDR-certified and HIPAA-compliant platform allowing fast and accurate variant discovery, annotation, and interpretation of NGS data for whole genomes, exomes, and gene panels, which helps clinicians reach faster and more accurate diagnoses and treatment decisions for genetic conditions. VarSome can also be integrated into existing in-house pipelines via VarSome API through cloud-based or on premises installations.

For more information about Saphetor SA and VarSome Clinical, please visit www.saphetor.com or contact sales@varsome.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240724536462/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Clarity AI Acquires ecolytiq, Further Expanding Its AI Sustainability Solutions to End Consumers9.7.2025 13:00:00 CEST | Press release

The acquisition expands on Clarity AI’s market leading climate engagement offering for global retail and commercial banking financial institutions Clarity AI, one of the world’s largest and most awarded technology and AI firms in sustainability, today announced the acquisition of ecolytiq, a leading provider of in-app climate engagement solutions for financial institutions and their millions of retail and commercial banking customers globally. This strategic move further reinforces Clarity AI’s position at the forefront of the rapidly expanding sustainability tech sector, strengthening its dominance in delivering impactful, data-driven solutions that empower individuals and organizations to make more sustainable choices. With this acquisition, Clarity AI expands its class-leading product portfolio, serving a broad spectrum of market participants—from institutional investors and global corporations to retail banks and individual consumers. The company’s modular, AI-powered platform is d

Valorem Reply Brings AI-powered Image Recognition to Art Basel’s Global Fairs9.7.2025 12:57:00 CEST | Press release

Valorem Reply, part of the Reply Group and focused on delivering innovative digital solutions with Microsoft technologies, partnered with Art Basel – a premier international art fair that hosts shows in Basel, Hong Kong, Miami Beach, Paris and Qatar – to enhance the visitor experience. In partnership with Microsoft, they developed Art Basel Lens, a feature within the Art Basel Companion app that uses image recognition to provide real-time information about artworks directly to visitors’ smartphones, making it easier to explore and engage with the art on display. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250709262853/en/ With Valorem Reply, Art Basel introduced a mobile image recognition feature that connects audiences to artworks using Microsoft Azure. By scanning an artwork, visitors receive structured content about the piece, the artist, and the gallery. The feature supports a more autonomous and fluid exploration of

Venture Global andSEFEAnnounceExpansion of LNG Partnership9.7.2025 12:19:00 CEST | Press release

Today, Venture Global, Inc. (NYSE: VG) and Securing Energy for Europe GmbH (SEFE) announced the finalization of an agreement under which SEFE’s subsidiary, SEFE Energy GmbH, will purchase an additional 0.75 million tonnes per annum (MTPA) of liquefied natural gas (LNG) from CP2 LNG, Venture Global’s third project, for 20 years. Today’s announcement amends the existing Sales and Purchase Agreement signed by the companies in 2023, increasing the total volume of LNG purchased by SEFE from CP2 LNG to 3.0 MTPA. Venture Global is expected to become Germany’s largest LNG supplier, with a combined 5 MTPA of 20-year offtake agreements signed with SEFE and EnBW. In addition to its existing long-term agreements, Venture Global to date has supplied Germany with almost 80 cargoes of LNG from its Calcasieu Pass and Plaquemines LNG facilities, enough to power 8 million German homes for one year. “Venture Global is thrilled to expand our strategic partnership with Germany and SEFE and play a leading r

The MasterFrame 600, Cooler Master's Modular Full Tower for High-End Builds, Now Available in Europe9.7.2025 10:02:00 CEST | Press release

Inspired by the FreeForm 2.0 philosophy, this revolutionary open-frame chassis is now available across Europe at an MSRP of €199 Cooler Master, a global leader in PC hardware and innovative thermal solutions, today announced the European sales kick-off of the MasterFrame 600, a high-end, modular open-frame full tower designed for power users, creators, and PC modders seeking total creative freedom and high-performance potential. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250709203901/en/ Cooler Master's MasterFrame 600 is built on our FreeForm 2.0 philosophy offering owners more customization options for personal builds. The MasterFrame 600 is available across Europe at a suggested retail price of €199, exclusively through select partners and resellers. Engineered on Cooler Master’s FreeForm 2.0 platform, the MasterFrame 600 redefines what’s possible in a premium PC chassis. This open-frame full tower delivers exceptiona

Kaneka Obtains Halal Certificate for KANEKA UBIQUINOL TM9.7.2025 03:30:00 CEST | Press release

Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Kazuhiko Fujii) (TOKYO:4118) has obtained “Halal Certificate (Certification Number: 355-TSRI/24)” for its functional food ingredient, KANEKA UBIQUINOLTM (active form of coenzyme Q10) powder, under the assessment of Shariah Research Institute of Takushoku University, and issued by JAPAN MUSLIM ASSOCIATION, a religious corporation, on May 28. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250708279133/en/ Halal certificate Halal certification is a system in which relevant organizations verify that products or services do not contain ingredients prohibited under Shariah (Islamic law) and certify their compliance with Shariah. We actively pursue the acquisition of various certifications to ensure the safety and security of our raw materials, and we are pleased to announce that we have obtained a Halal Certificate for KANEKA UBIQUINOLTM. Currently, the Muslim populati

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye